Female pattern hair loss (FPHL) androgenic alopcia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: Daily treatment with Oral Minoxidil Tablets (0.25 mg) and topical Placebo (1 CC twice a day) for one year. Intervention 2: Control group: Daily treatment with topic
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with female pattern hair loss androgenic alopcia ( with sinclair stgae between 2 and 5) based on clinical diagnosis and histopathology Age: between 18 and 50
Exclusion criteria
Exclusion criteria: Other causes of hair loss, including inflammatory and cicatricial hair loss The presence of other symptoms of hyperandrogenism (in particular, malaise and hirsutism), which is also evident in laboratory examination of hormonal disorders supported by polycystic ovaries, ovarian and adrenal tumors. Severe systemic disease (cardiovascular - renal - hepatic) A history of pressure drop or blood pressure less than 90/60 mmHg The patient's desire for pregnancy during one year is under study Taking any effective medication for alopecia, including hormonal medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair loss condition. Timepoint: Every 3 months. Method of measurement: based on Sinclair scale and shedding scale.;Evaluating the density and thickness of the hair. Timepoint: Every 3 months. Method of measurement: By trichoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure, weight. Timepoint: Weekly up to one month then monthly up to three months and then every three months. Method of measurement: Pressure gauge cuff, Weight gauge.;Liver, renal and electrolyte tests. Timepoint: The third and 12th month after starting treatment. Method of measurement: Blood sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahideh Saabeti
Mashhad University of Medical Sciences
Outcome results
None listed